Delivery Order SPE2DB20D1100-SPE2DB25FB3U2
Award Date
3/26/25
Potential Completion Date
3/27/25
Potential Value
$7.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $16,626.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the supply of Bydureon Bcise 2 mg autoinjectors, which are used to treat type 2 diabetes. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 mg autoinjectors, a medication used for the treatment of type 2 diabetes. The contract has a ceiling value of $4,157.22 and a period of performance through November 7, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 mg autoinjectors, a medication used to treat type 2 diabetes. The contract has a ceiling value of $3,240.42 and an ultimate completion date of March 31, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 MG Autoinjector 0.85 ML, a medication used in the treatment of diabetes. The contract has a ceiling value of $13,419.48 and a period of performance through April 20, 2023. The contract is a firm-fixed-price delivery order with no set-aside designation,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 mg auto-injector, a medication used in the treatment of type 2 diabetes. The contract has a ceiling value of $4,296.62 and an ultimate completion date of May 5, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,908.86 firm fixed-price contract is for the supply of Bydureon Bcise 2 mg autoinjectors, a medication used to treat type 2 diabetes. This delivery order is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,456.15, is for the supply of Bydureon BCISE 2 mg autoinjector syringes, a medication used for the treatment of type 2 diabetes. The contract has a firm fixed price pricing structure and an ultimate completion date of December 31, 2024. This contract is not designated as a set-aside....
This is a $6,464.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Bydureon BCISE 2 mg autoinjector medical devices, which are used for the treatment of diabetes. The contract has a performance period through February 26, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $47,211.38, is for the delivery of Bydureon BCISE 2 mg autoinjector 0.85 ml to support federal healthcare programs. The contract has an ultimate completion date of March 12, 2024 and is a firm fixed price delivery order. This award is associated with a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,595.58 firm fixed-price contract is for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml, a diabetes medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...